Christoforos Kosmidis
Overview
Explore the profile of Christoforos Kosmidis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
499
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Zarogoulidis P, Oikonomidou R, Petridis D, Huang H, Bai C, Perdokouri E, et al.
J Cancer
. 2024 Jan;
15(3):603-609.
PMID: 38213723
Lung cancer is known to be associated with chronic obstructive pulmonary disease. Moreover; nutritional status is associated with chronic obstructive disease treatment and lung cancer. Our aim was to evaluate...
12.
Katopodi T, Petanidis S, Anestakis D, Charalampidis C, Chatziprodromidou I, Floros G, et al.
Pharmaceutics
. 2023 Oct;
15(10).
PMID: 37896218
Following its therapeutic effect in hematological metastasis, chimeric antigen receptor (CAR) T cell therapy has gained a great deal of attention during the last years. However, the effectiveness of this...
13.
Varsamis N, Kosmidis C, Chatzimavroudis G, Apostolidou Kiouti F, Efthymiadis C, Lalas V, et al.
Diagnostics (Basel)
. 2023 Sep;
13(17).
PMID: 37685389
Background: we designed a prospective study of diagnostic accuracy that compared pelvic MRI and 3D-EAUS with pelvic MRI alone in the preoperative evaluation and postoperative outcomes of patients with perianal...
14.
Zarogoulidis P, Petridis D, Huang H, Bai C, Oikonomou P, Nikolaou C, et al.
Ther Deliv
. 2023 Aug;
14(8):491-498.
PMID: 37584210
Idiopathic pulmonary fibrosis is a rare disease with few efficient drugs in the market. The consequences of this disease are mainly respiratory failure and pulmonary hypertension. In our experiment we...
15.
Zarogoulidis P, Hohenforst-Schmidt W, Chen W, Porpodis K, Kosmidis C, Kotsakis A, et al.
J Cancer
. 2023 Jun;
14(9):1562-1570.
PMID: 37325061
Pulmonary nodules are common in the everyday clinical practice. There is always a diagnostic issue with this imaging finding. Based on the size we can use a variety of imaging...
16.
Kosmidis C, Sevva C, Magra V, Varsamis N, Koulouris C, Charalampous I, et al.
Diagnostics (Basel)
. 2023 Feb;
13(4).
PMID: 36832190
: One of the most known sexually transmitted diseases is Condylomata acuminata (CA), a skin lesion occurring due to infection from Human Papilloma Virus (HPV). CA has a typical appearance...
17.
Zarogoulidis P, Petridis D, Kosmidis C, Sapalidis K, Nena L, Matthaios D, et al.
Curr Oncol
. 2023 Feb;
30(2):1999-2006.
PMID: 36826116
Introduction: Cancer patients are known to experience sleep disturbances that differ between disease stages and treatments. Regarding lung cancer patients and immunotherapy, information on their sleep disturbances has been recently...
18.
Zarogoulidis P, Petridis D, Kosmidis C, Sapalidis K, Nena L, Matthaios D, et al.
Diseases
. 2023 Feb;
11(1).
PMID: 36810540
Introduction: Non-small-cell lung cancer is still diagnosed at an inoperable stage and systematic treatment is the only option. Immunotherapy is currently considered to be the tip of the arrow as...
19.
Katopodi T, Petanidis S, Tsavlis D, Anestakis D, Charalampidis C, Chatziprodromidou I, et al.
Front Oncol
. 2022 Nov;
12:1042125.
PMID: 36338748
The appearance of chemoresistance in cancer is a major issue. The main barriers to conventional tumor chemotherapy are undesirable toxic effects and multidrug resistance. Cancer nanotherapeutics were developed to get...
20.
Katopodi T, Petanidis S, Charalampidis C, Chatziprodromidou I, Eskitzis P, Tsavlis D, et al.
Cells
. 2022 Oct;
11(20).
PMID: 36291050
The tumor microenvironment plays a key role in progression of tumorigenesis, tumor progression, and metastasis. Accumulating data reveal that dendritic cells (DCs) appear to play a key role in the...